East Windsor, NJ, United States of America

Ashish Anvekar

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Acrotech Biopharma Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashish Anvekar. Retrieved from https://idiyas.com/inventor/ashish-anvekar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ashish Anvekar: Innovator in Pharmaceutical Compositions

Introduction

Ashish Anvekar is a notable inventor based in East Windsor, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug delivery and efficacy.

Latest Patents

Anvekar holds a patent for "Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof." This invention provides a high-dose oral pharmaceutical composition with a high drug loading of isotretinoin, featuring low fill-weight and smaller size capsules. The methods of preparation and use of this composition are designed to improve patient outcomes in the treatment of various conditions.

Career Highlights

Anvekar is currently associated with Acrotech Biopharma Inc., where he continues to work on advancing pharmaceutical technologies. His expertise in drug formulation and development has positioned him as a valuable asset in the industry.

Collaborations

Some of his coworkers include Nagaprasad Vishnubhotla and Arun Jana, who collaborate with him on various projects within the pharmaceutical sector.

Conclusion

Ashish Anvekar's innovative work in pharmaceutical compositions exemplifies the impact of dedicated inventors in improving healthcare solutions. His contributions are paving the way for more effective treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…